Twenty-four-hour serum growth hormone levels in maturity-onset diabetics
- PMID: 1183733
- DOI: 10.2337/diab.24.11.977
Twenty-four-hour serum growth hormone levels in maturity-onset diabetics
Abstract
Serum growth hormone, glucose, and insulin were studied every half hour during a twenty-four-hour period of "daily life" in four groups of subjects: nonobese normal subjects, obese normal subjects, nonobese maturity-onset diabetics, and obese maturity-onset diabetics. It was found that (1) serum growth horomone was uniformly low without meal- and sleep-related peaks in obese normals and diabetics. The twenty-four-hour serum growth hormone level was significantly higher in nonobese subjects than in obese subjects, in both diabetics and normals; (2) the twenty-four-hour serum growth hormone level was more fluctuating and significantly higher in nonobese diabetics than in nonobese normals; (3) there was no difference in the twenty-four-hour serum growth hormone level between obese diabetics and obese normals.
Similar articles
-
Twenty-four-hour somatostatin infusions in normals, juvenile diabetics, and maturity-onset diabetics.Metabolism. 1978 Sep;27(9 Suppl 1):1427-31. doi: 10.1016/0026-0495(78)90086-0. Metabolism. 1978. PMID: 683011 No abstract available.
-
Somatostatin in maturity-onset diabetes.Diabetes. 1978 Oct;27(10):1013-9. doi: 10.2337/diab.27.10.1013. Diabetes. 1978. PMID: 700257
-
Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.Diabetes. 1976 Oct;25(10):931-5. doi: 10.2337/diab.25.10.931. Diabetes. 1976. PMID: 976601
-
Isoproterenol-stimulated C-peptide and insulin secretion in diabetic and nonobese normal subjects: decreased hepatic extraction of endogenous insulin in diabetes.J Clin Endocrinol Metab. 1980 Nov;51(5):1143-9. doi: 10.1210/jcem-51-5-1143. J Clin Endocrinol Metab. 1980. PMID: 6999008
-
Effect of bromocriptine on maturity onset diabetes.Postgrad Med J. 1980 Jan;56(651):11-4. doi: 10.1136/pgmj.56.651.11. Postgrad Med J. 1980. PMID: 6992131 Free PMC article. Clinical Trial.
Cited by
-
Hypothalamic control of GH secretion: pathophysiology and clinical implications.Acta Neurochir (Wien). 1985;75(1-4):60-71. doi: 10.1007/BF01406324. Acta Neurochir (Wien). 1985. PMID: 2859744
-
A reappraisal of the blood glucose homeostat which comprehensively explains the type 2 diabetes mellitus-syndrome X complex.J Physiol. 2003 Jun 1;549(Pt 2):333-46. doi: 10.1113/jphysiol.2002.037895. Epub 2003 Apr 25. J Physiol. 2003. PMID: 12717005 Free PMC article. Review.
-
Autocrine and paracrine mechanisms in the early stages of diabetic nephropathy.J Endocrinol Invest. 1999 Oct;22(9):708-35. doi: 10.1007/BF03343635. J Endocrinol Invest. 1999. PMID: 10595837 Review. No abstract available.
-
Investigation of serum IGF-I levels amongst diabetic and non-diabetic cats.J Feline Med Surg. 2004 Jun;6(3):149-55. doi: 10.1016/j.jfms.2004.01.002. J Feline Med Surg. 2004. PMID: 15135351 Free PMC article.
-
Effect of recombinant human growth hormone treatment on insulin-like growth factor (IGF-I) levels in insulin-dependent diabetic patients.Acta Diabetol. 1995 Jun;32(2):131-4. doi: 10.1007/BF00569572. Acta Diabetol. 1995. PMID: 7579535
MeSH terms
Substances
LinkOut - more resources
Full Text Sources